Abstract
DRAXIMAGE, under exclusive licence from BTG International Ltd, is developing a technetium-99m formulation of ciprofloxacin (INFECTON), as a radioimaging agent for the potential diagnosis of infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis and tuberculosis.
MeSH terms
-
Animals
-
Ciprofloxacin / analogs & derivatives*
-
Ciprofloxacin / chemistry
-
Clinical Trials as Topic / statistics & numerical data
-
Drugs, Investigational* / chemistry
-
Humans
-
Infections / diagnosis
-
Organotechnetium Compounds* / chemistry
Substances
-
Drugs, Investigational
-
Organotechnetium Compounds
-
Technetium Tc 99m ciprofloxacin
-
Ciprofloxacin